Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from A Rapid and Sensitive LC–MS/MS Method for Quantification of NDSRI in Melatonin Drug Product via Controlled In Situ Formation. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1007/s10571-023-01324-w
10.1007/s10571-023-01324-w · External reference
10.3390/biom14020145
10.3390/biom14020145 · External reference
10.1021/acs.oprd.0c00224
10.1021/acs.oprd.0c00224 · External reference
10.1002/ajoc.201800437
10.1002/ajoc.201800437 · External reference
10.1021/acs.oprd.4c00115
10.1021/acs.oprd.4c00115 · External reference
10.1016/j.microc.2024.112439
10.1016/j.microc.2024.112439 · External reference
10.1016/j.xphs.2023.03.022
10.1016/j.xphs.2023.03.022 · External reference
10.1021/acs.oprd.3c00153
10.1021/acs.oprd.3c00153 · External reference
10.1016/j.smrv.2004.08.001
10.1016/j.smrv.2004.08.001 · External reference
Carcinogenic Potency Categorization Approach (CPCA) for Nitrosamines in Pharmaceuticals
2022 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1016/j.xphs.2023.03.007
10.1016/j.xphs.2023.03.007 · External reference
10.1093/chromsci/bmac059
10.1093/chromsci/bmac059 · External reference
Identification of Melatonin in Plants and Its Effects on Plasma Melatonin Levels and Binding to Melatonin Receptors in Vertebrates
1995 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Melatonin for Sleep Disorders in Children With Neurodevelopmental Disorders: Protocol for a Systematic Review With Meta‐Analysis and Trial Sequential Analysis of Randomised Clinical Trials
10.1136/bmjopen-2022-065520 · 2022 · External reference
Risk Assessment and Control Strategies for Nitrosamine Impurities in Pharmaceuticals
2023 · External reference
10.1007/s10337-025-04405-8
10.1007/s10337-025-04405-8 · External reference
10.1016/j.microc.2025.116252
10.1016/j.microc.2025.116252 · External reference
10.1039/d5an01052g
10.1039/d5an01052g · External reference
10.1007/s12247-025-10112-6
10.1007/s12247-025-10112-6 · External reference
10.2174/0929867329666220105115755
10.2174/0929867329666220105115755 · External reference
10.1111/j.1749-6632.2001.tb03627.x
10.1111/j.1749-6632.2001.tb03627.x · External reference
10.2174/092986710791233689
10.2174/092986710791233689 · External reference
Unresolved reference
2024 · External reference
10.1016/j.xphs.2023.02.024
10.1016/j.xphs.2023.02.024 · External reference
10.3390/children11030323
10.3390/children11030323 · External reference
10.1136/adc.2004.066498
10.1136/adc.2004.066498 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1016/j.jsps.2022.12.010
10.1016/j.jsps.2022.12.010 · External reference
